• Founded in 2009
  • Employees: 5

Description :

Xenikos is developing T-Guard, a therapeutic tool for resetting the body’s immune system in T-cell mediated diseases.

Headquarters :

Molenveldlaan 152A
6523RN Nijmegen

Related Posts

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.